194 related articles for article (PubMed ID: 15767558)
1. The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15.
Kim JS; Baek SJ; Sali T; Eling TE
Mol Cancer Ther; 2005 Mar; 4(3):487-93. PubMed ID: 15767558
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene.
Kim JH; Chang JH; Rhee KH; Yoon JH; Kwon SH; Song K; Lee KW; Cho CI; Jeon JH; Kim KS
Int J Cancer; 2008 Apr; 122(8):1765-73. PubMed ID: 18076062
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis.
Jang TJ; Kang HJ; Kim JR; Yang CH
Carcinogenesis; 2004 Oct; 25(10):1853-8. PubMed ID: 15180942
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drug sulindac sulfide suppresses structural protein Nesprin-2 expression in colorectal cancer cells.
Liggett JL; Choi CK; Donnell RL; Kihm KD; Kim JS; Min KW; Noegel AA; Baek SJ
Biochim Biophys Acta; 2014 Jan; 1840(1):322-31. PubMed ID: 24080406
[TBL] [Abstract][Full Text] [Related]
5. Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status.
Kim IY; Park SY; Kang Y; Thapa D; Choi HG; Kim JA
Arch Pharm Res; 2011 Feb; 34(2):323-30. PubMed ID: 21380817
[TBL] [Abstract][Full Text] [Related]
6. The integrated stress response-associated signals modulates intestinal tumor cell growth by NSAID-activated gene 1 (NAG-1/MIC-1/PTGF-beta).
Yang H; Park SH; Choi HJ; Moon Y
Carcinogenesis; 2010 Apr; 31(4):703-11. PubMed ID: 20130018
[TBL] [Abstract][Full Text] [Related]
7. The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells.
Kambe A; Yoshioka H; Kamitani H; Watanabe T; Baek SJ; Eling TE
Cancer Prev Res (Phila); 2009 Dec; 2(12):1088-99. PubMed ID: 19934343
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells.
Moon Y; Yang H; Kim YB
Toxicol Appl Pharmacol; 2007 Sep; 223(2):155-63. PubMed ID: 17599376
[TBL] [Abstract][Full Text] [Related]
10. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis.
Bottone FG; Martinez JM; Collins JB; Afshari CA; Eling TE
J Biol Chem; 2003 Jul; 278(28):25790-801. PubMed ID: 12734198
[TBL] [Abstract][Full Text] [Related]
11. The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac.
Wang X; Kingsley PJ; Marnett LJ; Eling TE
Cancer Prev Res (Phila); 2011 Jan; 4(1):150-60. PubMed ID: 21205743
[TBL] [Abstract][Full Text] [Related]
12. Sulindac sulfide induces autophagic death in gastric epithelial cells via survivin down-regulation: a mechanism of NSAIDs-induced gastric injury.
Chiou SK; Hoa N; Hodges A
Biochem Pharmacol; 2011 Jun; 81(11):1317-23. PubMed ID: 21458423
[TBL] [Abstract][Full Text] [Related]
13. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.
Han EK; Arber N; Yamamoto H; Lim JT; Delohery T; Pamukcu R; Piazza GA; Xing WQ; Weinstein IB
Breast Cancer Res Treat; 1998 Apr; 48(3):195-203. PubMed ID: 9598866
[TBL] [Abstract][Full Text] [Related]
14. Proapoptotic activity of NAG-1 is cell type specific and not related to COX-2 expression.
Jang TJ; Kim NI; Lee CH
Apoptosis; 2006 Jul; 11(7):1131-8. PubMed ID: 16699947
[TBL] [Abstract][Full Text] [Related]
15. Relative non-steroidal anti-inflammatory drug (NSAID) antiproliferative activity is mediated through p21-induced G1 arrest and E2F inhibition.
Bock JM; Menon SG; Goswami PC; Sinclair LL; Bedford NS; Domann FE; Trask DK
Mol Carcinog; 2007 Oct; 46(10):857-64. PubMed ID: 17415779
[TBL] [Abstract][Full Text] [Related]
16. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
17. A novel anticancer effect of Astragalus saponins: Transcriptional activation of NSAID-activated gene.
Auyeung KK; Cho CH; Ko JK
Int J Cancer; 2009 Sep; 125(5):1082-91. PubMed ID: 19384947
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.
Zerbini LF; Tamura RE; Correa RG; Czibere A; Cordeiro J; Bhasin M; Simabuco FM; Wang Y; Gu X; Li L; Sarkar D; Zhou JR; Fisher PB; Libermann TA
PLoS One; 2011; 6(9):e24285. PubMed ID: 21931671
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.
Moon Y; Bottone FG; McEntee MF; Eling TE
Mol Cancer Ther; 2005 Oct; 4(10):1551-8. PubMed ID: 16227405
[TBL] [Abstract][Full Text] [Related]
20. Id-1 gene downregulation by sulindac sulfide and its upregulation during tumor development in gastric cancer.
Jang TJ; Jung KH; Choi EA
Int J Cancer; 2006 Mar; 118(6):1356-63. PubMed ID: 16184548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
